Cargando…

Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes

BACKGROUND: Prostate tumor overexpressed 1 (PTOV1) has been reported to contribute to increased cancer proliferation. However, the clinical significance of PTOV1 in the development and progression of nasopharyngeal carcinoma (NPC) is unclear. Our study aimed to investigate the expression pattern of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qi, Lin, Huanxin, Wu, Shu, Lei, Fangyong, Zhu, Xi, Song, Libing, Hong, Minghuang, Guo, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549246/ https://www.ncbi.nlm.nih.gov/pubmed/26305455 http://dx.doi.org/10.1371/journal.pone.0136448

Ejemplares similares

Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression
por: Alaña, Lide, et al.
Publicado: (2014)

Prognostic significance of PTOV1 expression in cancers: A protocol for systematic review and meta-analysis
por: Yang, Yue, et al.
Publicado: (2021)

Prostate Tumor Overexpressed 1 Is a Novel Prognostic Marker for Hepatocellular Carcinoma Progression and Overall Patient Survival
por: Chen, Shu-Peng, et al.
Publicado: (2015)

Seroprevalence of porcine torovirus (PToV) in Spanish farms
por: Alonso-Padilla, Julio, et al.
Publicado: (2012)

Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma
por: Li, Wen-Fei, et al.
Publicado: (2012)

Molecular characterization of a new PToV strain. Evolutionary implications
por: Pignatelli, J., et al.
Publicado: (2009)

Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
por: Lin, Shaojun, et al.
Publicado: (2014)

Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma
por: Huang, Pei-Yu, et al.
Publicado: (2016)

Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis
por: Liao, Kuang-Ming, et al.
Publicado: (2016)

Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells
por: Karna, Shibendra Kumar Lal, et al.
Publicado: (2019)

LncRNA PTOV1-AS2 Promotes Colon Cancer Progression through the miR-145-5p/FSCN1 Axis
por: Zhang, Zhen, et al.
Publicado: (2023)

hnRNPK-regulated PTOV1-AS1 modulates heme oxygenase-1 expression via miR-1207-5p
por: Shin, Chang Hoon, et al.
Publicado: (2017)

Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer
por: Guo, Jia, et al.
Publicado: (2016)

Molecular epidemiology of Porcine torovirus (PToV) in Sichuan Province, China: 2011–2013
por: Zhou, Lu, et al.
Publicado: (2014)

PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer
por: Shen, Hongwei, et al.
Publicado: (2021)

Overexpression of Semaphorin 3A is a Marker Associated with Poor Prognosis in Patients with Nasopharyngeal Carcinoma
por: Imoto, Tomoko, et al.
Publicado: (2020)

Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival
por: Wang, Dan, et al.
Publicado: (2019)

Lineage specific antigenic differences in porcine torovirus hemagglutinin-esterase (PToV-HE) protein
por: Pignatelli, Jaime, et al.
Publicado: (2013)

Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25
por: Landrieu, Isabelle, et al.
Publicado: (2015)

Porcine Torovirus (PToV)—A Brief Review of Etiology, Diagnostic Assays and Current Epidemiology
por: Hu, Zhang-Min, et al.
Publicado: (2019)

Longitudinal serological and virological study on porcine torovirus (PToV) in piglets from Spanish farms
por: Pignatelli, J., et al.
Publicado: (2010)

Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma
por: Shan, Ying, et al.
Publicado: (2017)

FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker
por: Chen, Qiuyan, et al.
Publicado: (2016)

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2020)

Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits
por: Wu, Zhiqiang, et al.
Publicado: (2019)

Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer
por: Li, Yilong, et al.
Publicado: (2019)

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
por: Fu, Xin, et al.
Publicado: (2016)

Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer
por: Liu, Jing-bo, et al.
Publicado: (2019)

High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer
por: Kim, Mee Young, et al.
Publicado: (2019)

CK1α overexpression correlates with poor survival in colorectal cancer
por: Richter, Julia, et al.
Publicado: (2018)

ALDH1B1 predicts poor survival for locally advanced nasopharyngeal carcinoma patients
por: Zhu, Tao, et al.
Publicado: (2022)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
por: Chen, Chaojiang, et al.
Publicado: (2020)

URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer
por: Zhang, Lan, et al.
Publicado: (2014)

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis
por: Zhang, Yan, et al.
Publicado: (2010)

Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma
por: Liu, Yijun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p4nfjf09dd3vkd8befvl7gcpa0